- Home
- SMHI vs MIST Comparison
SMHI vs MIST Comparison
Compare SMHI & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMHI
- MIST
- Stock Information
- Founded
- SMHI 1989
- MIST 2003
- Country
- SMHI United States
- MIST Canada
- Employees
- SMHI N/A
- MIST N/A
- Industry
- SMHI Marine Transportation
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- SMHI Consumer Discretionary
- MIST Health Care
- Exchange
- SMHI Nasdaq
- MIST Nasdaq
- Market Cap
- SMHI 186.4M
- MIST 164.9M
- IPO Year
- SMHI N/A
- MIST N/A
- Fundamental
- Price
- SMHI $6.35
- MIST $1.82
- Analyst Decision
- SMHI
- MIST Strong Buy
- Analyst Count
- SMHI 0
- MIST 3
- Target Price
- SMHI N/A
- MIST $6.33
- AVG Volume (30 Days)
- SMHI 63.3K
- MIST 1.6M
- Earning Date
- SMHI 10-29-2025
- MIST 11-11-2025
- Dividend Yield
- SMHI N/A
- MIST N/A
- EPS Growth
- SMHI N/A
- MIST N/A
- EPS
- SMHI N/A
- MIST N/A
- Revenue
- SMHI $255,033,000.00
- MIST N/A
- Revenue This Year
- SMHI N/A
- MIST N/A
- Revenue Next Year
- SMHI $9.97
- MIST N/A
- P/E Ratio
- SMHI N/A
- MIST N/A
- Revenue Growth
- SMHI N/A
- MIST N/A
- 52 Week Low
- SMHI $3.63
- MIST $0.63
- 52 Week High
- SMHI $8.61
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- SMHI 48.42
- MIST 40.33
- Support Level
- SMHI $5.80
- MIST $1.76
- Resistance Level
- SMHI $6.48
- MIST $1.95
- Average True Range (ATR)
- SMHI 0.30
- MIST 0.09
- MACD
- SMHI 0.03
- MIST -0.03
- Stochastic Oscillator
- SMHI 54.84
- MIST 15.55
About SMHI SEACOR Marine Holdings Inc.
Seacor Marine Holdings Inc provides marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that deliver cargo and personnel to offshore installations, including wind farms, handle anchors, and mooring equipment for offshore rigs and platforms. Its geographical segment includes the United States (Gulf of Mexico), Africa and Europe, Middle East and Asia, and Latin America.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).